Goldman Sachs Group Inc I Bio, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

May 14, 2024
BUY
$0.23 - $0.46 $67,560 - $135,121
293,743 New
293,743 $78,000
Q2 2022

Aug 15, 2022
BUY
$0.23 - $0.46 $37,872 - $75,745
164,664 Added 127.57%
293,743 $78,000
Q1 2022

May 16, 2022
SELL
$0.3 - $0.61 $70,893 - $144,149
-236,310 Reduced 64.67%
129,079 $55,000
Q4 2021

Feb 14, 2022
BUY
$0.55 - $1.04 $71,394 - $135,001
129,809 Added 55.1%
365,389 $201,000
Q3 2021

Nov 10, 2021
BUY
$1.06 - $1.52 $249,714 - $358,081
235,580 New
235,580 $250,000

About iBio, Inc.

IBIO Quotes by TradingView
  • Ticker IBIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,006,580
  • Market Cap $23.8M
  • Description
  • iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...
More about IBIO
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email